RegeneRx Biopharmaceuticals Inc (RGRX)

[All City Baby]

This is to inform you of the progress of the clinical phase 3 (ARISE-3) of eye dry eye treatment under Corona19.

By GtreeBNT 17 March 2020 - Notice

http://gtreebnt.com/2020/03/17/%ec%bd%94%eb%a1%9c%eb%82%9819%ec%97%90-%eb%94%b0%eb%a5%b8-%ec%95%88%ea%b5%ac%ea%b1%b4%ec%a1%b0%ec%a6%9d%ec%b9%98%eb%a3%8c%ec%a0%9c-%ec%9e%84%ec%83%81-3%ec%83%81arise-3-%ec%a7%84%ed%96%89-%ec%82%ac/

Arrange emergency measures that can be carried out without delays or delays in accordance with Korona19.

This clinical triangulation (ARISE-3) compares the safety and effectiveness of RGN-259 against placebo with a two-week clinical dose of 700 eye-dry patients at ophthalmic clinics across the United States.

During the clinical process of the AISE-3 clinical trial, we visited the Clinical Trustees (CROs) in person against possible regulations in the U.S. in response to the judgment that various regulations, such as the World Health Organization's Pandemic Declaration and restrictions on movement in the U.S., could affect clinicians due to Corona19.

Through this meeting, we will work to achieve our goal of ending the medication and to derive successful clinical results within this year by establishing a contingency plan, such as positioning the clinical sites in the U.S. and positioning emergency organizations in a key geographical location.

We will also work closely with the clinical trust agency to actively respond to changing conditions in the United States.

Currently, there is no major disruption or delay in the clinical process or schedule of ARISE-3 in the wake of the U.S. COVID-19 incident. In the future, we promise to notify our shareholders through Gitribianity's web-site, along with immediate action, in the case of any necessary modifications in the clinical plan of ARISE-3 which remains through the ongoing real-time status check of U.S. COVID-19.

-----------------------------------------------------------

https://www.stars21.com/translator/korean_to_english.html (NaverStar translation)